Video Latest - ecancer

Analysis of iron status in paediatric acute lymphoblastic leukaemia

Dr Charlotte Brierley - Royal Hospital for Sick Children, Edinburgh, UK

6 May 2015

New approaches to diffuse large B-cell lymphoma

Dr Andrew Davies - University Hospital Southampton NHS Foundation Trust, Southampton, UK

6 May 2015

Latest in novel approaches to CLL and MCL

Professor Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK

6 May 2015

Comment: Metastatic triple-negative breast cancer responds to immunotherapy

Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA

1 May 2015

Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer

Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst, Australia

1 May 2015

Comment: Research developments stir hopes for melanoma

Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA

1 May 2015

Certain classes of genes in patients that could lead to prostate cancer

Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA

1 May 2015

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA

1 May 2015

Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer

Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA

1 May 2015

Pembrolizumab found to be safe with durable responses in advanced non-small cell lung cancer

Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA

1 May 2015

PARP inhibitor combo shows early promise for patients with and without BRCA mutations

Dr Timothy Yap - Royal Marsden Hospital, London, UK

1 May 2015

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanoma

Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA

1 May 2015

Video